Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Monopar Therapeutics Inc. (MNPR) had Return on Tangible Equity of -2.88% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-3.89M |
|
-- |
|
-- |
|
$5.23M |
|
$-5.23M |
|
$1.33M |
|
$-3.89M |
|
$-3.89M |
|
$-3.89M |
|
$-3.89M |
|
$-3.89M |
|
$-3.89M |
|
$-5.23M |
|
$-6.02M |
|
8.54M |
|
8.54M |
|
$-0.46 |
|
$-0.46 |
|
| Balance Sheet Financials | |
$137.74M |
|
-- |
|
$0.24M |
|
$137.98M |
|
$2.46M |
|
-- |
|
$0.13M |
|
$2.59M |
|
$135.39M |
|
$135.39M |
|
$135.39M |
|
6.70M |
|
| Cash Flow Statement Financials | |
$-3.47M |
|
$-5.58M |
|
$-0.20M |
|
$61.83M |
|
$52.54M |
|
$-9.29M |
|
$1.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
56.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.47M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-2.88% |
|
|
Return on Tangible Equity |
-2.88% |
-2.82% |
|
-2.88% |
|
$20.21 |
|
$-0.41 |
|
$-0.41 |
|